PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
The tendency of mitochondria to undergo or resist BCL2-controlled apoptosis (so-called mitochondrial priming) is a powerful predictor of response to cytotoxic chemotherapy. Fully exploiting this